HOME >> BIOLOGY >> NEWS
Promising cell protein may play role in infection and dry eye

Plasminogen Activator Inhibitor Type 2 (PAI-2), a protein found in various cell types including the skin, has been discovered in the tissue covering the eye and may have future clinical implications in various pathologies of the ocular surface such as eye infection or dry eye, according to researchers at the University of Pennsylvania and Temple University.

The researchers, led by Mina Massaro-Giordano, M.D., of the University of Pennsylvania's Scheie Eye Institute, and Marcella Macaluso, Ph.D., of the Sbarro Institute for Cancer Research at Temple University (www.shro.org), published their study,

"Cytoplasmic and nuclear interaction between Rb family proteins and PAI-2: a physiological crosstalk in human corneal and conjunctival epithelial cells," in Cell Death and Differentiation (www.nature.com/cdd).

They recently presented their findings at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Florida, which was attended by over 10,000 researchers.

PAI-2, in either extracellular or secreted form, is a multifunctional protein that plays a role in cell differentiation, in prevention of programmed cell death, in the regulation of cell proliferation, in the inhibition of microbial proteinases and in the protection against stromal degradation.

High levels of the PAI-2 protein are associated with a good prognosis in breast cancer, small cell lung, ovarian cancer, and inhibition of metastasis. PAI-2 also plays a role in inflammation on the surface of the eye.

In their study, the Penn and Temple researchers demonstrate for the first time an interaction between PAI-2 and the tumor suppressing gene Rb2/p130 in the nucleus of the epithelial cells in the cornea and conjunctiva.

According to the researchers, this interaction with Rb2/p130 and chromatin modeling enzymes may affect how PAI-2 is expressed. <
'"/>

Contact: Preston M. Moretz
pmoretz@temple.edu
215-204-7476
Temple University
16-May-2006


Page: 1 2

Related biology news :

1. Promising protein may prevent eye damage in premature babies
2. Tailored treatments: Promising designer drug provides new insight into cancer biology
3. Promising antiobesity drug fails to produce clinically meaningful weight loss
4. Promising preclinical results with live attenuated H5N1 vaccines
5. Promising new research on hereditary diseases
6. Promising anti-TB compound finally can be synthesized with ease
7. Promising results in the battle against incurable ALS muscle disease
8. Promising new preventative treatment option for population of men at high risk of prostate cancer
9. Penn researchers discover how key protein stops inflammation
10. UCF research links proteins, stem cells and potential Alzheimers treatment
11. Teamwork between 2 key proteins necessary for normal development and regulation of red blood cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2018)... ... , ... Lajollacooks4u is proud to have hosted a variety of groups this year – both ... Illumina, Qualcomm, Hewlett Packard, Sequenom and more, have all visited the La Jolla-based venue time ... of the reason clientele return is due to Lajollacooks4u’s signature team-building format, a way for ...
(Date:8/21/2018)... ... August 20, 2018 , ... ... software solutions for biopharma R&D, today announced that Seattle-based Aptevo Therapeutics ... solution provider. Aptevo will use the Genedata Biologics ® platform to ...
(Date:8/17/2018)... DENVILLE, N.J. and LIEGE, Belgium (PRWEB) , ... ... ... Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service ... epigenetics services including a number of targeted DNA methylation assays using pyrosequencing ...
Breaking Biology News(10 mins):
(Date:8/31/2018)... Ore. (PRWEB) , ... August 29, 2018 , ... ... Associate Professorships at both the University of Southampton and the Institute of Industrial ... artificial intelligence at sea can dramatically accelerate the exploration and study of hard ...
(Date:8/29/2018)... ... ... Cognition Corporation ®, a software company specializing in medical device compliance ... , Ryan Ward, Director of Engineering at Zimmer Biomet, has been announced as a ... with Zimmer Biomet for almost 15 years, Mr. Ward will focus his talk about ...
(Date:8/29/2018)... ... August 28, 2018 , ... LabRoots , the leading provider of ... proud to announce the launch of a new gamification feature, allowing users to earn ... one of LabRoots most popular shirts. , Throughout each month, LabRoots users will earn ...
(Date:8/26/2018)... ... August 24, 2018 , ... ... cell-derived exosomes dramatically relieves atopic dermatitis and inhibits a variety of inflammatory targets ... the paper, the symptoms of mice having severe atopic dermatitis were significantly improved ...
Breaking Biology Technology:
Cached News: